Clinical Microbiology Procedures Handbook Volumes 1-3

Content: Dedication --
contents --
editorial board --
how to use this handbook --
abbreviations --
preface --
acknowledgments --
reader response form --
disclaimer --
Volume 1 --
Procedure coding, reimbursement, and billing compliance --
Chapter 1.1 : introduction --
Chapter 1.2 : procedure coding, reimbursement, and billing compliance --
Specimen collection, transport, and acceptability --
Chapter 2.1 : collection, transport, and manipulation of clinical specimens and initial laboratory concerns --
Aerobic bacteriology --
Chapter 3.1 : introduction to the section --
Chapter 3.2 : staining procedures --
Chapter 3.3 : processing, isolation, detection, and interpretation of aerobic bacteriology cultures --
Chapter 3.4 : blood cultures --
Chapter 3.5 : body fluid cultures (excluding blood, cerebrospinal fluid, and urine) --
Chapter 3.6 : catheter tip cultures --
Chapter 3.7 : cerebrospinal fluid cultures --
Chapter 3.8 : fecal and other gastrointestinal cultures and toxin assays --
Chapter 3.9 : genital cultures --
Chapter 3.10 : ocular cultures --
Chapter 3.11 : respiratory tract cultures --
Chapter 3.12 : urine cultures --
Chapter 3.13 : wound cultures --
Chapter 3.14 : leptospira culture --
Chapter 3.15 : mycoplasma pneumoniae, mycoplasma hominis, and ureaplasma cultures from clinical specimens --
Chapter 3.16 : guidelines for biochemical identification of aerobic bacteria --
Chapter 3.17 : biochemical tests for the identification of aerobic bacteria --
Chapter 3.18 : schemes for identification of aerobic bacteria --
Anaerobic bacteriology --
Chapter 4.1 : introduction --
Chapter 4.2 : collection and transport of clinical specimens for anaerobic culture --
Chapter 4.3 : culture media for anaerobes --
Chapter 4.4 : examination of primary culture plates for anaerobic bacteria --
Chapter 4.5 : incubation techniques for anaerobic bacteriology specimens --
Chapter 4.6 : rapid disk, spot tests, and other methods for the identification of anaerobes --
Chapter 4.7 : commercial kit overnight biochemical systems for the identification of anaerobes --
Chapter 4.8 : rapid enzymatic systems for the identification of anaerobes --
Chapter 4.9 : rapid biochemical tests (4 hours or less) for the identification of anaerobes --
Chapter 4.10 : anaerobic gram-negative bacilli --
Chapter 4.11 : anaerobic gram-positive bacilli --
Chapter 4.12 : anaerobic cocci --
Chapter 4.13 : suggestions for a practical scheme for the workup of anaerobic cultures --
Chapter 4.14 : clostridium difficile as a pathogen involved in antimicrobial agent-associated diarrhea, colitis, and pseudomembranous colitis. Volume 3 --
Viruses and chlamydiae --
Chapter 10.1 : laboratory diagnosis of viral infections: introduction --
Chapter 10.2 : selection, maintenance, and observation of uninoculated monolayer cell cultures --
Chapter 10.3 : cell culture techniques: serial propagation and maintenance of monolayer cell cultures --
Chapter 10.4 : specimen collection and processing --
Chapter 10.5 : viral culture: isolation of viruses in cell cultures --
Chapter 10.6 : isolation of chlamydia spp. In cell culture --
Chapter 10.7 : direct detection of viruses and chlamydia in clinical samples --
Immunology --
Chapter 11.1 : immunology introduction --
Chapter 11.2 : serologic diagnosis of group a streptococcal infections --
Chapter 11.3 : detection of legionella antigen by direct immunofluorescence --
Chapter 11.4 : urinary antigen detection for legionella spp. --
Chapter 11.5 : laboratory diagnosis of syphilis --
Chapter 11.6 : detection of borrelia burgdorferi antibodies --
Chapter 11.7 : serodiagnosis of rickettsial infections --
Chapter 11.8 : immunoassay detection of shiga toxin-producing escherichia coli --
Chapter 11.9 : serodiagnosis of helicobacter pylori --
Chapter 11.10 : total viable cell counting procedure --
Chapter 11.11 : peripheral blood mononuclear cell cryopreservation method --
Chapter 11.12 : lymphocyte proliferation assay --
Chapter 11.13 : natural killer cell assays --
Chapter 11.14 : quantitation of human interleukin 4, interleukin 6, and gamma interferon --
Chapter 11.15 : flow cytometry whole-blood intracellular-cytokine assay using phorbol myristate acetate, ionomycin, and brefeldin a --
Chapter 11.16 : whole-blood lymphocyte immunophenotyping using cell surface markers by flow cytometry --
Chapter 11.17 : neutrophil function whole-blood flow cytometric test for leukocyte adhesion deficiency --
Chapter 11.18 : flow cytometric test for chronic granulomatous disease --
Chapter 11.19 : gamma interferon enzyme-linked immunospot assay --
Molecular diagnostics --
Chapter 12.1 : introduction --
Chapter 12.2 : molecular methods for direct detection of microorganisms in clinical specimens --
Chapter 12.3 : molecular methods for identification of cultured microorganisms --
Chapter 12.4 : molecular methods for epidemiologic typing of microorganisms --
Chapter 12.5 : molecular methods for antimicrobial agent resistance determination --
Chapter 12.6 : appendix 12.6-1 --
unidirectional work flow and minimization of contamination --
Epidemiologic and infection control microbiology --
Chapter 13.1 : introduction --
Chapter 13.2 : laboratory support for infection control: optimization by policy and procedure --
Chapter 13.3 : policies for environmental sampling and culturing for infection control --
Chapter 13.4 : outbreak investigations: laboratory and epidemiologic concepts --
Chapter 13.5 : epidemiologic strain typing --
Chapter 13.6 : culture of hospital water for legionellaceae. Chapter 13.7 : culture and endotoxin assay of hemodialysis fluids --
Chapter 13.8 : culture of peritoneal dialysis fluid --
Chapter 13.9 : air cultures for fungi --
Chapter 13.10 : microbiological assay of environmental and medical-device surfaces --
Chapter 13.11 : surveillance cultures from immunocompromised hosts --
Chapter 13.12 : culture of intravascular devices --
Chapter 13.13 : culture of blood bank products --
Chapter 13.14 : microbiological assessment of orthopedic surgery sites --
Chapter 13.15 : quantitative culture of small-bowel contents --
Chapter 13.16 : phenotypic characterization of organisms for epidemiologic purposes --
Chapter 13.17 : screening for methicillin-resistant staphylococcus aureus --
Chapter 13.18 : screening for vancomycin-resistant enterococci --
Quality assurance, quality control, laboratory records, and water quality --
Chapter 14.1 : quality assessment and improvement (quality assurance) --
Chapter 14.2 : quality control --
Chapter 14.3 : laboratory records --
Chapter 14.4 : preparation and quality control of laboratory water --
Biohazards and safety --
Chapter 15.1 : introduction --
Chapter 15.2 : biological safety and biohazard prevention --
Chapter 15.3 : biohazard containment --
Chapter 15.4 : laboratory instrumentation and equipment --
Chapter 15.5 : special pathogens and employee safety --
Chapter 15.6 : packing and shipping infectious substances --
Chapter 15.7 : management of laboratory accidents --
Chapter 15.8 : management of infectious waste --
Bioterrorism --
Chapter 16.1 : general introduction to bioterrorism --
Chapter 16.2 : levels of laboratory safety --
Chapter 16.3 : packing and shipping select agents --
Chapter 16.4 : anthrax --
bacillus anthracis --
Chapter 16.5 : botulinumtoxin --
clostridium botulinum --
Chapter 16.6 : brucellosis --
brucella spp. --
Chapter 16.7 : plague --
yersinia pestis --
Chapter 16.8 : tularemia --
francisella tularensis --
Chapter 16.9 : melioidosis (burkholderia pseudomallei) and glanders (burkholderia mallei) --
Chapter 16.10 : smallpox --
variola major --
Chapter 16.11 : unknown virus --
Chapter 16.12 : q fever --
coxiella burnetii --
Chapter 16.13 : clinical laboratory bioterrorism readiness plan --
Chapter 16.14 : avian influenza --
Index.